SCHEMBL7525215

SCHEMBL7525215

Cc1[nH]c2ccccc2c1C1=C(c2cccc(N)c2)C(=O)NC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 3/20 0.53
GSK3B P49841 2/20 0.53
CAMK2D Q13557 2/20 0.48
PRKCB P05771 2/20 0.45
PRKCH P24723 2/20 0.45
PRKCE Q02156 2/20 0.45
PRKCQ Q04759 2/20 0.45
PRKCD Q05655 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CHEK1 O14757 1/20 0.42
WEE1 P30291 1/20 0.42
BRD4 O60885 1/20 0.42
CREBBP Q92793 1/20 0.42
IMPDH2 P12268 1/20 0.42
PARP1 P09874 2/20 0.41
CCR6 P51684 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
AURKA O14965 1/20 0.41
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15797114 0.85 PRKCB (0.54) PRKCAGSK3BCAMK2DPRKCBPRKCH
SCHEMBL19217082 0.85 CAMK2D (0.46) PRKCAGSK3BCAMK2DPRKCBPRKCH
SCHEMBL5686050 0.84 CAMK2D (0.57) PRKCAGSK3BCAMK2DPRKCBPRKCH
SCHEMBL20243386 0.83 CAMK2D (0.55) PRKCACAMK2DPRKCBPRKCHPRKCE
SCHEMBL15797184 0.81 PDE9A (0.49) PRKCAGSK3BCAMK2DPRKCBPRKCH
SCHEMBL8317513 0.79 CAMK2D (0.50) PRKCAGSK3BCAMK2DPRKCBPRKCH
SCHEMBL19217027 0.78 IMPDH2 (0.67) PRKCACAMK2DPRKCBPRKCHPRKCE
SCHEMBL19217028 0.78 GSK3B (0.51) PRKCAGSK3BCAMK2DPRKCBPRKCH
SCHEMBL22592333 0.76 PDE9A (0.51) PRKCAGSK3BCAMK2DPRKCBPRKCH
SCHEMBL19216926 0.76 PRKCB (0.48) PRKCACAMK2DPRKCBPRKCHPRKCE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020188018-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta GONG LEYI (US) 2002-12-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020188018-A1 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta GSK3B, GSK3A, PYGL PRKCA 62/4885GSK3B 1/4885CAMK2D 329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.